First approved medication for tardive dyskinesia demonstrates safety, study shows

A recently FDA-approved medication for the movement disorder tardive dyskinesia is safe and well tolerated, according to neurologists presenting results from a yearlong monitoring study.

Source: Medical Xpress

Read more